Erin L. Kirk

2.1k total citations · 1 hit paper
38 papers, 1.4k citations indexed

About

Erin L. Kirk is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Erin L. Kirk has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cancer Research, 18 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Erin L. Kirk's work include Breast Cancer Treatment Studies (16 papers), Cancer Risks and Factors (8 papers) and Cancer Genomics and Diagnostics (7 papers). Erin L. Kirk is often cited by papers focused on Breast Cancer Treatment Studies (16 papers), Cancer Risks and Factors (8 papers) and Cancer Genomics and Diagnostics (7 papers). Erin L. Kirk collaborates with scholars based in United States, South Africa and China. Erin L. Kirk's co-authors include Melissa A. Troester, Jeffery C. Rathmell, Alex J. Freemerman, Amy R. Johnson, Pankuri Goraksha-Hicks, Liza Makowski, Andrew N. Macintyre, J. Justin Milner, Charles M. Perou and Xuezheng Sun and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Erin L. Kirk

36 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic Reprogramming of Macrophages

2014 715 citations Erin L. Kirk, Melissa A. Troester et al. profile →

Peers

Countries citing papers authored by Erin L. Kirk

Since Specialization

Citations

This map shows the geographic impact of Erin L. Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin L. Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin L. Kirk more than expected).

Fields of papers citing papers by Erin L. Kirk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin L. Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin L. Kirk. The network helps show where Erin L. Kirk may publish in the future.

Co-authorship network of co-authors of Erin L. Kirk

This figure shows the co-authorship network connecting the top 25 collaborators of Erin L. Kirk. A scholar is included among the top collaborators of Erin L. Kirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin L. Kirk. Erin L. Kirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status 2024 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Matthew R. Dunn, Alina M. Hamilton, (unknown), Xiaohua Gao, Erin L. Kirk, (unknown), Lisa A. Carey, Yara Abdou, Katherine E. Reeder‐Hayes, Mya L. Roberson, Stephanie B. Wheeler, Marc A. Emerson, Terry Hyslop, Melissa A. Troester	7
2	Associations of Prostate Tumor Immune Landscape with Vigorous Physical Activity and Prostate Cancer Progression 2024 ·Cancer Epidemiology Biomarkers & Prevention ·Lanshan Huang, (unknown), (unknown), Alina M. Hamilton, (unknown), Erin L. Kirk, Laura Farnan, (unknown), Stephanie G. Craig, Stephen P. Finn, Melissa J. LaBonte, Suneil Jain, Melissa A. Troester, Eboneé N. Butler, Jeannette T. Bensen, Sara E. Wobker, Emma H. Allott	0
3	Differences in 21-Gene and PAM50 Recurrence Scores in Younger and Black Women With Breast Cancer 2024 ·JCO Precision Oncology ·(unknown), (unknown), (unknown), Alina M. Hamilton, Xiaohua Gao, Erin L. Kirk, Eboneé N. Butler, H. Shelton Earp, Katherine E. Reeder‐Hayes, Katherine A. Hoadley, Lisa A. Carey, Melissa A. Troester	1
4	Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay 2023 ·Breast Cancer Research and Treatment ·Amber N. Hurson, Alina M. Hamilton, (unknown), Erin L. Kirk, Mark E. Sherman, Benjamin C. Calhoun, Joseph Geradts, Melissa A. Troester	5
5	RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast Cancer 2022 ·Cancer Epidemiology Biomarkers & Prevention ·Andrea Walens, (unknown), (unknown), (unknown), (unknown), Xiaohua Gao, Alina M. Hamilton, Erin L. Kirk, Michael I. Love, Gaorav P. Gupta, Charles M. Perou, Cyrus Vaziri, Katherine A. Hoadley, Melissa A. Troester	9
6	Quantitative analysis of breast cancer tissue composition and associations with tumor subtype 2022 ·Human Pathology ·(unknown), Lindsay A. Williams, Bentley R. Midkiff, Erin L. Kirk, Melissa A. Troester, Benjamin C. Calhoun	8
7	Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer 2021 ·Clinical Cancer Research ·Jeffrey S. Damrauer, Kyle R. Roell, (unknown), Xuezheng Sun, Erin L. Kirk, Katherine A. Hoadley, Halei C. Benefield, Gopa Iyer, David B. Solit, Matthew I. Milowsky, William Y. Kim, Matthew E. Nielsen, Sara E. Wobker, Guido Dalbagni, Hikmat Al‐Ahmadie, Andrew F. Olshan, Bernard H. Bochner, Helena Furberg, Melissa A. Troester, Eugene J. Pietzak	33
8	Hepatocyte growth factor pathway expression in breast cancer by race and subtype 2021 ·Breast Cancer Research ·Gieira S. Jones, Katherine A. Hoadley, (unknown), Alina M. Hamilton, Arjun Bhattacharya, Erin L. Kirk, (unknown), Jodie M. Fleming, Michael I. Love, Hazel B. Nichols, Andrew F. Olshan, Melissa A. Troester	6
9	Protein-based immune profiles of basal-like vs. luminal breast cancers 2021 ·Laboratory Investigation ·Andrea Walens, (unknown), Xiaohua Gao, Alina M. Hamilton, Erin L. Kirk, Stephanie M. Cohen, Bentley R. Midkiff, (unknown), Mark E. Sherman, Nana Nikolaishvili‐Feinberg, Jonathan S. Serody, Katherine A. Hoadley, Melissa A. Troester, Benjamin C. Calhoun	9
10	Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features 2020 ·JNCI Cancer Spectrum ·Halei C. Benefield, Katherine E. Reeder‐Hayes, Hazel B. Nichols, Benjamin C. Calhoun, Michael I. Love, Erin L. Kirk, Joseph Geradts, Katherine A. Hoadley, Stephen R. Cole, H. Shelton Earp, Andrew F. Olshan, Lisa A. Carey, Charles M. Perou, Melissa A. Troester	13
11	Using Digital Pathology to Understand Epithelial Characteristics of Benign Breast Disease among Women Undergoing Diagnostic Image-Guided Breast Biopsy 2019 ·Cancer Prevention Research ·Maeve Mullooly, (unknown), Shaoqi Fan, Ruth M. Pfeiffer, (unknown), (unknown), Erin L. Kirk, Pamela M. Vacek, Donald L. Weaver, John Shepherd, Amir Pasha Mahmoudzadeh, Jeff Wang, Serghei Malkov, Jason M. Johnson, Stephen M. Hewitt, Sally D. Herschorn, Mark E. Sherman, Melissa A. Troester, Gretchen L. Gierach	1
12	Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications 2019 ·Breast Cancer Research and Treatment ·Emma H. Allott, Yue Shan, Mengjie Chen, Xuezheng Sun, Susana García‐Recio, Erin L. Kirk, Andrew F. Olshan, Joseph Geradts, H. Shelton Earp, Lisa A. Carey, Charles M. Perou, Ruth M. Pfeiffer, William F. Anderson, Melissa A. Troester	10
13	Vascular density of histologically benign breast tissue from women with breast cancer: associations with tissue composition and tumor characteristics 2019 ·Human Pathology ·Ashley M. Fuller, (unknown), Bentley R. Midkiff, Erin L. Kirk, Kirk K. McNaughton, Benjamin C. Calhoun, Melissa A. Troester	3
14	PAM50 and Risk of Recurrence Scores for Interval Breast Cancers 2018 ·Cancer Prevention Research ·(unknown), Sarah J. Nyante, Cherie M. Kuzmiak, Mengjie Chen, Chiu-Kit Tse, Xuezheng Sun, Emma H. Allott, Erin L. Kirk, Lisa A. Carey, Charles M. Perou, Andrew F. Olshan, Louise M. Henderson, Melissa A. Troester	6
15	Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue 2018 ·PLoS ONE ·Xuezheng Sun, Delisha A. Stewart, Rupninder Sandhu, Erin L. Kirk, Wimal Pathmasiri, Susan McRitchie, Robert Clark, Melissa A. Troester, Susan Sumner	2
16	Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast 2018 ·Modern Pathology ·Lynn Chollet‐Hinton, (unknown), Rupninder Sandhu, Erin L. Kirk, Bentley R. Midkiff, Karthik Ghosh, Kathleen R. Brandt, Christopher G. Scott, Gretchen L. Gierach, Mark E. Sherman, Celine M. Vachon, Melissa A. Troester	8
17	Obesity-Associated Alterations in Inflammation, Epigenetics, and Mammary Tumor Growth Persist in Formerly Obese Mice 2016 ·Cancer Prevention Research ·Emily L. Rossi, (unknown), Laura W. Bowers, Subreen A. Khatib, Laura Smith, Eric Van Buren, Priya Bhardwaj, Dilip D. Giri, Marcos R. Estecio, Melissa A. Troester, Brionna Y. Hair, Erin L. Kirk, Ting Gong, Jianjun Shen, Andrew J. Dannenberg, Stephen D. Hursting	41
18	Body mass index associated with genome-wide methylation in breast tissue 2015 ·Breast Cancer Research and Treatment ·Brionna Y. Hair, Zongli Xu, Erin L. Kirk, Sophia Harlid, Rupninder Sandhu, Whitney R. Robinson, Michael C. Wu, Andrew F. Olshan, Kathleen Conway, Jack A. Taylor, Melissa A. Troester	24
19	Digital histologic analysis reveals morphometric patterns of age-related involution in breast epithelium and stroma 2015 ·Human Pathology ·Rupninder Sandhu, Lynn Chollet‐Hinton, Erin L. Kirk, Bentley R. Midkiff, Melissa A. Troester	15
20	p53 and NF-κB Coregulate Proinflammatory Gene Responses in Human Macrophages 2014 ·Cancer Research ·Julie M. Lowe, Daniel Menéndez, Pierre R. Bushel, Maria Shatz, Erin L. Kirk, Melissa A. Troester, Stavros Garantziotis, Michael B. Fessler, Michael A. Resnick	138

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact